prikaz prve stranice dokumenta A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
  Preuzmi
PDF 125.95 KB
Znanstveni rad - Izvorni znanstveni rad
A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
Journal of the Neurological Sciences, 248 (2006), 1-2; 251-254. https://doi.org/10.1016/j.jns.2006.05.027
Relja, Maja; Klepac, Nataša

Citirajte ovaj rad

Relja, M. i Klepac, N. (2006). A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease. Journal of the Neurological Sciences, 248. (1-2), 251-254. doi: 10.1016/j.jns.2006.05.027

Relja, Maja i Nataša Klepac. "A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease." Journal of the Neurological Sciences, vol. 248, br. 1-2, 2006, str. 251-254. https://doi.org/10.1016/j.jns.2006.05.027

Relja, Maja i Nataša Klepac. "A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease." Journal of the Neurological Sciences 248, br. 1-2 (2006): 251-254. https://doi.org/10.1016/j.jns.2006.05.027

Relja, M. i Klepac, N. (2006) 'A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease', Journal of the Neurological Sciences, 248(1-2), str. 251-254. doi: 10.1016/j.jns.2006.05.027

Relja M, Klepac N. A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease. Journal of the Neurological Sciences [Internet]. 25.10.2006. [pristupljeno 19.12.2024.];248(1-2):251-254. doi: 10.1016/j.jns.2006.05.027

M. Relja i N. Klepac, "A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease", Journal of the Neurological Sciences, vol. 248, br. 1-2, str. 251-254, Listopad 2006. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:928422. [Citirano: 19.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:928422
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
AutorMaja Relja
AutorNataša Klepac
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
The cognitive performance of 55 non-demented idiopathic Parkinson's disease (PD) patients treated with levodopa alone or receiving dopamine agonist pramipexole as add-on therapy to levodopa was evaluated in the present study during 6 months of treatment. Neuropsychological tests were administered two times. In the first assessment to differentiate test sensitive to cognitive changes typical for PD control group was also assessed. After 6 months of treatment PD patients were retested only with tests that differentiate them from control group. Compared to controls PD patients showed inferior performance on Stroop Interference test, Trail Making test, letter fluency and Hooper Visual Organization Test. No statistically significant differences between two groups and first and second neuropsychological assessment were found. Present findings indicate that pramipexole as add-on therapy to levodopa is safe in non-demented PD patients in terms of the effect on cognitive performance.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaJournal of the Neurological Sciences
Brojčani podacivol. 248, br. 1-2, str. 251-254
p-ISSN0022-510X
DOIhttps://doi.org/10.1016/j.jns.2006.05.027
URN:NBNurn:nbn:hr:105:928422
Datum objave publikacije2006-10-25
URL dokumentahttps://doi.org/10.1016/j.jns.2006.05.027
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-27 19:21:46